JP2003146870A - Lipid degradation promoter and method of slimming body - Google Patents

Lipid degradation promoter and method of slimming body

Info

Publication number
JP2003146870A
JP2003146870A JP2001344250A JP2001344250A JP2003146870A JP 2003146870 A JP2003146870 A JP 2003146870A JP 2001344250 A JP2001344250 A JP 2001344250A JP 2001344250 A JP2001344250 A JP 2001344250A JP 2003146870 A JP2003146870 A JP 2003146870A
Authority
JP
Japan
Prior art keywords
lipolysis
skin
slimming
promoter
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001344250A
Other languages
Japanese (ja)
Inventor
Takeshi Ikemoto
毅 池本
Miki Mori
美希 森
Yuurikei Sato
友里恵 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP2001344250A priority Critical patent/JP2003146870A/en
Publication of JP2003146870A publication Critical patent/JP2003146870A/en
Pending legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a lipid degradation promoter that is very effective for improvement of the obese constitution by reducing fatty tissues of the whole body or local parts thereof, or for inhibiting and preventing the obesity by inhibiting the lipid tissues from being increased. SOLUTION: The lipid degradation promoter is a compound represented by general formula (1). The lipid decomposition promoter is used by adding to external preparations for skin and to drink and food.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、全身もしくは局所
の脂肪組織の減少を促進することによる肥満体質の改
善、又は同組織の増大を防止することによる肥満の抑制
もしくは防止に有効な脂肪分解促進剤及び皮膚外用剤並
びに飲食品組成物に関する。
TECHNICAL FIELD The present invention relates to improvement of the obesity constitution by promoting a decrease in systemic or local adipose tissue, or promotion of lipolysis effective in suppressing or preventing obesity by preventing the increase of the adipose tissue. And an external preparation for skin and a food and drink composition.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】体内の
脂肪は、消費エネルギーに対し、摂取エネルギーの過剰
分が、白色脂肪細胞の中性脂肪として蓄積して生じる物
である。体脂肪としての蓄積が大きい肥満は、美容上好
ましくないばかりでなく、動脈硬化等の様々な疾病を引
き起こす。最近、過食、運動不足、ストレス等による肥
満が増加しているが、反面、特に女性は外見上からもス
リムな引き締まった体を切望する傾向にある。また、皮
下脂肪等の蓄積は、健康上も好ましくなく、皮下脂肪等
の減少、もしくは蓄積の防止が重要な問題となってい
る。
2. Description of the Related Art Fat in the body is a product in which excess amount of ingested energy with respect to consumed energy is accumulated as neutral fat of white adipocytes. Obesity, which is highly accumulated as body fat, is not only cosmetically unfavorable but also causes various diseases such as arteriosclerosis. Recently, obesity due to overeating, lack of exercise, stress, etc. is increasing, but on the other hand, especially women tend to long for a slim body. Further, accumulation of subcutaneous fat and the like is unfavorable for health, and reduction of subcutaneous fat or prevention of accumulation is an important issue.

【0003】肥満防止作用を有する物質としてトウガラ
シ等に含まれるカプサイシン類は血中のアルブミンと結
合し、副腎の代謝を促進するホルモンを分泌し、肝臓や
脂肪細胞に作用してエネルギー代謝を活発化することが
知られている(岩井和夫及び中谷延二著、香辛料成分の
食品機能、97頁、1989年)。しかしながら、カプ
サイシン類は強い刺激を有しているために、その用途や
使用量を限定される問題があった。
Capsaicin, which is contained in capsicum as a substance having an obesity-preventing action, binds to albumin in the blood, secretes hormones that promote metabolism of the adrenal gland, and acts on the liver and adipocytes to activate energy metabolism. It is known (Kazuo Iwai and Yanji Nakatani, Food functions of spice ingredients, page 97, 1989). However, since capsaicins have a strong stimulus, there is a problem that their use and usage amount are limited.

【0004】一度蓄積した脂肪細胞を無くすのは難し
く、脂肪細胞をなるべく小さくすることが早道であり、
そのためには脂肪中の油滴を分解することが必要である
と考えた。油滴は蛋白質と同じように酵素(ホスホリパ
ーゼC)によって分解されるが、油滴は水をはじくリン
脂質の膜に覆われているために油滴周辺の小包体という
水の固まりの中にいる酵素は近づくことができない。一
方、運動することで交感神経を活発にすることにより脂
肪分解ホルモンが分泌される。このホルモンはリン脂質
の膜を取り除き、酵素と油滴の親和性を高めることで脂
肪分解を促進すると考えられている。そこで、このホル
モンと同様に油滴と酵素の親和性を高める働きをもつ物
質を見つけることが必要であると考えられていた。
It is difficult to eliminate the fat cells that have once accumulated, and it is a quick way to make the fat cells as small as possible.
For that purpose, we thought that it was necessary to decompose the oil droplets in the fat. Oil drops are decomposed by an enzyme (phospholipase C) like proteins, but because they are covered with a water-repelling phospholipid membrane, they are in a mass of water called parcels around oil drops. Enzymes are inaccessible. On the other hand, by exercising to activate the sympathetic nerve, a lipolytic hormone is secreted. It is believed that this hormone promotes lipolysis by removing the phospholipid membrane and increasing the affinity between the enzyme and oil droplets. Therefore, it was considered necessary to find a substance that acts to increase the affinity between the oil droplet and the enzyme, like this hormone.

【0005】本発明者等は、ラズベリーケトンやジンゲ
ロン及びその誘導体が脂肪組織に蓄積された脂肪の分解
を促進し、肥満の抑制、又は肥満体質の改善に有効であ
ることを見出している(特開2000−169325号
公報)。しかしながら、ラズベリーケトンやジンゲロン
は特有の芳香を有しているために配合量や汎用性の点に
おいて満足できるものではなかった。
The present inventors have found that raspberry ketone, zingerone and their derivatives promote the decomposition of fat accumulated in adipose tissue, and are effective in suppressing obesity or improving obesity constitution (Japanese Patent Laid-Open No. 2004-242242). 2000-169325). However, since raspberry ketone and zingerone have unique fragrances, they were not satisfactory in terms of compounding amount and versatility.

【0006】一方、イヌゴマやオリーブに含まれる3,
4−ジヒドロキシフェネチルアルコール(ヒドロキシチ
ロソール)には優れた免疫抑制効果や活性酸素消去作用
があることが知られているが(特開平2−306971
号公報、特開平7−223940号公報)、本物質が脂
肪分解促進作用を有していることは何ら記載も示唆もな
されていない。
On the other hand, 3, which is contained in sesame seeds and olives,
It is known that 4-dihydroxyphenethyl alcohol (hydroxytyrosol) has an excellent immunosuppressive effect and active oxygen scavenging effect (JP-A-2-306971).
JP-A No. 7-223940), there is no description or suggestion that this substance has a lipolysis promoting action.

【0007】そこで、より汎用特性に優れ、かつ皮下脂
肪等を抑制又は減少させる満足な効果を有する脂肪分解
促進剤及び痩身方法が望まれている。したがって、本発
明は汎用特性に優れ、かつ全身もしくは局所の脂肪組織
の減少を促進することによる肥満体質の改善、又は同組
織の増大を防止することによる肥満の抑制もしくは防止
に有効な脂肪分解促進剤及び痩身方法を提供することを
目的とするものである。
Therefore, there is a demand for a lipolysis promoter and a slimming method which are more versatile and have a satisfactory effect of suppressing or reducing subcutaneous fat and the like. Therefore, the present invention has excellent general-purpose properties, and improves the obesity constitution by promoting the reduction of systemic or local adipose tissue, or promotes lipolysis effective in suppressing or preventing obesity by preventing the increase of the same tissue. It is intended to provide a drug and a slimming method.

【0008】[0008]

【課題を解決するための手段】上記の目的を達成するた
めに、本発明者等は脂肪細胞に作用し脂肪分解を促進す
る作用を有する物質について鋭意研究した結果、下記一
般式(1)で示される化合物が、上記作用を有し、脂肪
組織に蓄積された脂肪の分解を促進し、肥満の抑制、又
は肥満体質の改善に有効であることを見出し、本発明を
完成した。
In order to achieve the above object, the inventors of the present invention have conducted extensive studies on a substance having an action of acting on adipocytes and promoting lipolysis, and as a result, the following general formula (1) It was found that the compound shown has the above-mentioned effects, promotes the decomposition of fat accumulated in adipose tissue, is effective in suppressing obesity or improving obesity constitution, and completed the present invention.

【0009】[0009]

【化4】 [Chemical 4]

【0010】即ち、本発明は、上記一般式(1)で示さ
れるヒドロキシチロソールからなる脂肪分解促進剤及び
該化合物を含有することを特徴とする皮膚外用剤並びに
痩身用飲食品組成物にある。
That is, the present invention resides in a lipolysis promoter comprising hydroxytyrosol represented by the above general formula (1) and a skin external preparation and a food / beverage composition for slimming containing the compound. .

【0011】[0011]

【発明の実施の形態】以下、本発明に関し、詳説する。
本発明に用いる前記一般式(1)で表されるヒドロキシ
チロソールは、特開平7−223940号公報に記載さ
れているようにイヌゴマからの抽出により容易に得るこ
とができる。また、オリーブ及び/もしくはオリーブ油
製造工程に産するベジテーション水等から適当な溶媒に
よって抽出し、必要により公知の方法で濃縮や乾固、精
製して用いることもできる。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below.
The hydroxytyrosol represented by the general formula (1) used in the present invention can be easily obtained by extraction from sesame seeds as described in JP-A-7-223940. Further, it can be used by extracting from olives and / or vegetation water produced in the olive oil production process with a suitable solvent, and if necessary, concentrating, drying, and purifying by a known method.

【0012】前記一般式(1)で表されるヒドロキシチ
ロソールは、脂肪分解促進剤として、皮膚外用剤又は痩
身用飲食品組成物に用いる場合、その配合量は製剤の形
態によっても種々異なり一概に規定できるものではない
が、例えば、該組成物中に0.001〜20質量%配合
するのが好ましく、さらには0.01〜10質量%が好
ましい。0.001質量%未満では本発明の効果を奏し
ない場合があり、20質量%を越えて配合しても、配合
量に見合った効果が得られない場合がある。
When the hydroxytyrosol represented by the above general formula (1) is used as a lipolysis promoter in a skin external preparation or a slimming food / beverage composition, the compounding amount varies depending on the form of the preparation. However, for example, 0.001 to 20% by mass is preferable, and 0.01 to 10% by mass is more preferable. If the amount is less than 0.001% by mass, the effect of the present invention may not be exhibited, and if the amount exceeds 20% by mass, the effect corresponding to the compounded amount may not be obtained.

【0013】本発明の脂肪分解促進剤を痩身用皮膚外用
剤に用いる場合には、通常の皮膚外用剤において使用さ
れる、油分、顔料、界面活性剤、保湿剤、紫外線吸収
剤、抗炎症剤、殺菌剤、防腐剤、色素等の他に、ブトパ
ミン、イソプロテレノール等のβアドレナリン作用興奮
剤、ヨヒンビン、エルゴトキシン等のα2アドレナリン
作用抑制剤、テオフィリン、カフェイン等のキサンチン
誘導体、ミルリノン、アムリノン等のビピリジン誘導体
等、肥満の抑制又は防止作用を有するラズベリーケト
ン、ジンゲロン、3,4−ジヒドロキシフェニル−2−
ブタノンやシネフリン等の公知物質等を配合することが
できる。
When the lipolysis-promoting agent of the present invention is used as a skin external preparation for slimming, oils, pigments, surfactants, humectants, ultraviolet absorbers, anti-inflammatory agents used in ordinary skin external preparations are used. In addition to bactericides, preservatives, pigments, butadamine, isoproterenol, and other β-adrenergic stimulants, yohimbine, ergotoxin, and other α2-adrenergic inhibitors, theophylline, caffeine, and other xanthine derivatives, milrinone, amrinone Raspberry ketone, zingerone, 3,4-dihydroxyphenyl-2-, which has an action of suppressing or preventing obesity, such as bipyridine derivatives
Known substances such as butanone and synephrine may be added.

【0014】本発明の脂肪分解促進剤を痩身用飲食品組
成物に用いる場合には、通常の飲食品組成物において使
用される糖類、香料、乳化剤、乳製品、蛋白質、安定
剤、着色料、酸味料、油脂、穀類、卵類、ガムベース、
カフェイン等のキサンチン誘導体、ハイドロキシクエン
酸、肥満の抑制又は防止作用を有するカプサイシン、ラ
ズベリーケトン、ジンゲロン、3−4−ジヒドロキシフ
ェニル−2−ブタノンやシネフリン等の公知物質等を配
合することができる。
When the lipolysis-promoting agent of the present invention is used in a slimming food / beverage composition, sugars, flavors, emulsifiers, dairy products, proteins, stabilizers, colorants, which are used in ordinary food / beverage compositions, Acidulant, oil, cereal, egg, gum base,
Xanthine derivatives such as caffeine, hydroxycitric acid, known substances such as capsaicin, raspberry ketone, zingerone, 3-4-dihydroxyphenyl-2-butanone and synephrine, which have an obesity-suppressing or preventing action, can be added.

【0015】本発明の脂肪分解促進剤は、例えば、食
品、経口投与薬、皮膚化粧料等に配合することができ、
剤型は特に限定されるものではなく痩身用皮膚化粧料等
の皮膚外用剤の場合には、皮膚塗布用、浴用、洗浄用等
のクリーム、乳液、ジェル、スティック、シート、パッ
プ、粉末、液体、顆粒等、飲食品組成物の場合にはチュ
ーインガム、チョコレート、キャンディ、グミゼリー、
飲料、スープ、アイスクリーム、麺類、ベーカリー食品
等に配合することができる。
The lipolysis promoter of the present invention can be incorporated into, for example, foods, orally administered drugs, skin cosmetics, etc.
The dosage form is not particularly limited, and in the case of an external preparation for skin such as slimming skin cosmetics, cream for skin application, bath, cleaning etc., emulsion, gel, stick, sheet, pap, powder, liquid , Granules and the like, in the case of food and drink composition, chewing gum, chocolate, candy, gummy jelly,
It can be added to beverages, soups, ice creams, noodles, bakery foods and the like.

【0016】[0016]

【実施例】以下、本発明を実施例、比較例に基づき、詳
説する。尚、脂肪分解促進効果の評価として、下記の脂
肪分解試験、皮下脂肪分解試験にて評価した。
EXAMPLES The present invention will be described in detail below based on examples and comparative examples. The lipolysis promoting effect was evaluated by the following lipolysis test and subcutaneous lipolysis test.

【0017】[脂肪分解試験法]ロッドベルの方法〔R
odbell,M.,J.Biol.Chem.,23
9,375(1964)〕により、ウィスター系雄性ラ
ット(体重150〜200g)の副睾丸脂肪組織からコ
ラゲナーゼ溶液を用いて遊離脂肪細胞を調製した。被験
物濃度を所定量となるよう調製した牛血清アルブミン及
びノルエピネフリン(最終濃度0.05μg/mL)を
含むハンクス緩衝液中に上記細胞を加え、37℃にて1
時間反応した。遊離した脂肪酸を抽出し、銅試薬及び発
色試薬により脂肪酸量を定量した。
[Lipolysis test method] Rodbell method [R
odbell, M .; J. Biol. Chem. , 23
9, 375 (1964)], free adipocytes were prepared from epididymal adipose tissue of male Wistar rats (body weight: 150 to 200 g) using a collagenase solution. The above cells were added to a Hanks buffer solution containing bovine serum albumin and norepinephrine (final concentration 0.05 μg / mL) prepared so that the concentration of the test substance was a predetermined amount, and the cells were allowed to stand at 37 ° C. for 1 hour.
Reacted for hours. The liberated fatty acid was extracted, and the amount of fatty acid was quantified with a copper reagent and a coloring reagent.

【0018】 脂肪分解促進率(%)=[A/B]×100 A:被験物添加時の脂肪酸量 B:コントロール(被験物無添加)の脂肪酸量[0018] Lipolysis promotion rate (%) = [A / B] × 100 A: Fatty acid amount when the test substance was added B: Amount of fatty acid in control (without addition of test substance)

【0019】実施例1(ヒドロキシチロソール画分の製
造) 南仏製オリーブ油の製造工程に生じる水層部から種子等
の絞り粕を除去し得たベジテーション水20リットルを
等量のヘキサンにて洗浄した後に20リットルの酢酸エ
チルにてヒドロキシチロソールを含むポリフェノール画
分を抽出した。常法により抽出溶媒を除去することで本
発明で用いる脂肪分解促進剤約60gを得た。図1に示
した様に得られた脂肪分解促進剤には約25%のヒドロ
キシチロソールが含まれていることをGC−MSにより
確認した。
Example 1 (Production of hydroxytyrosol fraction) 20 liters of vegetation water obtained by removing squeezed lees such as seeds from the aqueous layer produced in the production process of olive oil made in South France was washed with an equal amount of hexane. After that, the polyphenol fraction containing hydroxytyrosol was extracted with 20 liters of ethyl acetate. The extraction solvent was removed by a conventional method to obtain about 60 g of a lipolysis promoter used in the present invention. It was confirmed by GC-MS that the lipolysis promoter obtained as shown in FIG. 1 contained about 25% hydroxytyrosol.

【0020】実施例2(ヒドロキシチロソールの分離精
製) 実施例1で得た脂肪分解促進剤10gをシリカゲルカラ
ムクロマトグラフィー(展開溶媒;石油エーテル/酢酸
エチル=1/1)にて精製することにより3.5gのヒ
ドロキシチロソールを得た。GC分析により、その純度
は95%以上であることを確認した。
Example 2 (Separation and purification of hydroxytyrosol) 10 g of the lipolysis promoter obtained in Example 1 was purified by silica gel column chromatography (developing solvent; petroleum ether / ethyl acetate = 1/1). 3.5 g of hydroxytyrosol was obtained. It was confirmed by GC analysis that the purity was 95% or higher.

【0021】実施例3、4及び比較例1、2 各種脂肪分解促進剤について、上記の脂肪分解試験にて
評価した結果を以下に示す。
Examples 3 and 4 and Comparative Examples 1 and 2 The results of evaluation of the various lipolysis promoters in the above lipolysis test are shown below.

【0022】 脂肪分解促進剤 試験濃度 脂肪分解促進率(%) 実施例3 実施例2のヒドロキシチロソール 0.05% 163.4± 3.5 p<0.001 実施例4 実施例2のヒドロキシチロソール 0.50% 182.9±12.1 p<0.001 比較例1 ラズベリーケトン 0.02% 118.3±11.6 n.s. 比較例2 ラズベリーケトン 0.20% 143.6± 8.1 p<0.001[0022] Lipolysis promoter Test concentration Lipolysis promotion rate (%)                                                                    Example 3   Hydroxytyrosol of Example 2 0.05% 163.4 ± 3.5                                                     p <0.001                                                                    Example 4   Hydroxytyrosol of Example 2 0.50% 182.9 ± 12.1                                                     p <0.001                                                                    Comparative Example 1   Raspberry ketone 0.02% 118.3 ± 11.6                                                         n. s.                                                                    Comparative example 2   Raspberry ketone 0.20% 143.6 ± 8.1                                                     p <0.001

【0023】実施例2で得た脂肪分解促進剤(ヒドロキ
シチロソール)は、脂肪分解促進率が比較例で用いた
(特開2000−169325号公報において脂肪分解
作用が知られた)ラズベリーケトンに比べはるかに高く
脂肪分解促進作用が高いことが明らかにされた。
The lipolysis-promoting agent (hydroxytyrosol) obtained in Example 2 had a lipolysis-promoting rate higher than that of the raspberry ketone used in Comparative Examples (known to have a lipolytic action in JP-A 2000-169325). It was clarified that the effect of promoting lipolysis was much higher.

【0024】実施例5、比較例3〜4(チューインガ
ム) 下記組成のチューインガムに有効成分を各々配合し、2
0代で体脂肪率35%以上の女性30名に毎日1日5枚
のチューインガム(15g/枚)を1ヶ月摂取させ、体
脂肪率が元の体脂肪率よりも5%以上低下した場合を体
脂肪減少者として評価した。 実施例5 比較例3 比較例4 ガムベース 20 20 20 マルチトール 73.5 74.5 70.5 還元水あめ 4 4 4 アップル香料 0.5 0.5 0.5 ガルシニアエキス *1 1 1 5 ヒドロキシチロソ−ル(実施例2) 1 − − 評価 体脂肪減少者数(人) 23 11 20 *1 ガルシニアエキス: インターヘルス社製「シトリマックスHCA−500−F」(ヒドロキシクエ ン酸(HCA)47.5質量%含有)
Example 5, Comparative Examples 3 to 4 (Chewing Gum) Each chewing gum having the following composition was blended with an active ingredient, and 2
When 30 women with a body fat percentage of 35% or more in their 0s took 5 chewing gums (15 g / sheet) daily for 1 month each day, and the body fat percentage decreased by 5% or more from the original body fat percentage, It was evaluated as a person with reduced body fat. Example 5 Comparative Example 3 Comparative Example 4 Gum base 20 20 20 Maltitol 73.5 74.5 70.5 Reduced starch syrup 4 4 4 Apple fragrance 0.5 0.5 0.5 0.5 Garcinia extract * 1 1 1 5 Hydroxytyroso -(Example 2) 1 --- Evaluation Number of persons with reduced body fat (person) 23 11 20 * 1 Garcinia extract: "Citrimax HCA-500-F" (hydroxycitric acid (HCA) 47.5, manufactured by Interhealth) (Mass% included)

【0025】実施例6(錠菓) 下記組成で錠菓を調製し、1日3錠(0.5g/錠)を
実施例5と同様に摂取させて評価した。組成 ソルビトール 82.9 ショ糖脂肪酸エステル 4 ラズベリー香料 0.1 ガルシニアエキス *1 3 実施例1の脂肪分解促進剤 10 評価 体脂肪減少者(人) 25
Example 6 (tablet confectionery) A tablet confectionery was prepared with the following composition, and 3 tablets (0.5 g / tablet) were ingested daily and evaluated in the same manner as in Example 5. Composition Sorbitol 82.9 Sucrose fatty acid ester 4 Raspberry fragrance 0.1 Garcinia extract * 1 3 Lipolysis accelerator of Example 1 10 Evaluation Body fat reducer (person) 25

【0026】以上の様に実施例5及び6は、有意に体脂
肪率低下作用が見られ、かつ長期にわたって摂取しても
飽きがこない、連食に適した飲食品組成物であった。
As described above, Examples 5 and 6 were food / beverage compositions suitable for continuous eating, in which the effect of significantly lowering the body fat percentage was observed, and the composition did not become tired even after long-term intake.

【0027】実施例7〜8、比較例5(ジェル状痩身用
皮膚化粧料) 以下に示す組成で、常法によりA、B各成分を個別に混
合溶解後、B成分をA成分に添加し攪拌することによ
り、ジェル状痩身用皮膚化粧料を調製した。
Examples 7 to 8 and Comparative Example 5 (Gel-like slimming skin cosmetics) In the following composition, components A and B were individually mixed and dissolved by a conventional method, and then component B was added to component A. The gel cosmetic for slimming was prepared by stirring.

【0028】 配合成分(質量%) 実施例7 実施例8 比較例5 (A成分) 実施例1の脂肪分解促進剤 3.0 − − 実施例2の ヒドロキシチロソール − 1.0 − グリセリン 10.0 10.0 10.0 カルボキシビニルポリマー 0.3 0.3 0.3 エデト酸二ナトリウム 0.1 0.1 0.1 精製水 残 量 残 量 残 量 ジイソプロパノールアミン 1.0 1.0 1.0 スクワラン 10.0 10.0 10.0 (B成分) ポリオキシエチレン(60) 0.8 0.8 0.8 硬化ヒマシ油 カラギーナン 3.0 3.0 3.0 キサンタンガム 3.0 3.0 3.0 ポリビニルアルコール 2.0 2.0 2.0 エタノール 45.0 45.0 45.0 メントール 0.1 0.1 0.1 香料 適 量 適 量 適 量[0028] Ingredients (mass%) Example 7 Example 8 Comparative Example 5 (A component) Lipolysis promoter of Example 1 3.0 − − Of Example 2   Hydroxytyrosol-1.0- Glycerin 10.0 10.0 10.0 10.0 Carboxy vinyl polymer 0.3 0.3 0.3 Edetate disodium 0.1 0.1 0.1 Purified water Residual amount Residual amount Diisopropanolamine 1.0 1.0 1.0 Squalane 10.0 10.0 10.0 (B component) Polyoxyethylene (60) 0.8 0.8 0.8       Hydrogenated castor oil Carrageenan 3.0 3.0 3.0 3.0 Xanthan gum 3.0 3.0 3.0 Polyvinyl alcohol 2.0 2.0 2.0 Ethanol 45.0 45.0 45.0 Menthol 0.1 0.1 0.1 Perfume Suitable amount Suitable amount Suitable amount

【0029】上記ジェル状痩身用皮膚化粧料を実施例5
のパネルの腹部及び大腿部に2gを一日2回、3週間連
用塗布した後に痩身効果についてのアンケート結果、実
施例7及び8を用いたパネルは腹部等が引き締まったと
回答した者が比較例5と比してはるかに多かった。
Example 5 was applied to the above gel-like slimming skin cosmetic composition.
After the continuous application of 2 g to the abdomen and thighs of the panel of Example 2 twice a day for 3 weeks, the results of the questionnaire about the slimming effect, the panel using Examples 7 and 8 showed that the abdomen was tightened. Much more than 5.

【0030】[0030]

【発明の効果】本発明は、全身あるいは局所の脂肪組織
を減少させ、肥満の抑制又は防止、肥満体質の改善に有
効な脂肪分解促進剤、及び該脂肪分解促進剤を用いるこ
とを特徴とする痩身方法を提供できることは明らかであ
る。
INDUSTRIAL APPLICABILITY The present invention is characterized by using a lipolysis promoter which is effective in reducing systemic or local adipose tissue, suppressing or preventing obesity, and improving obesity constitution, and the lipolysis promoter. It is clear that a slimming method can be provided.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4B018 LB01 MD08 ME01 4C083 AC022 AC102 AC122 AC432 AC471 AC532 AC542 AD092 AD112 AD352 BB41 CC02 DD41 EE10 EE12 EE50 4C206 AA01 AA02 CA19 KA01 MA72 MA83 NA14 ZA70    ─────────────────────────────────────────────────── ─── Continued front page    F-term (reference) 4B018 LB01 MD08 ME01                 4C083 AC022 AC102 AC122 AC432                       AC471 AC532 AC542 AD092                       AD112 AD352 BB41 CC02                       DD41 EE10 EE12 EE50                 4C206 AA01 AA02 CA19 KA01 MA72                       MA83 NA14 ZA70

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(1) 【化1】 からなる脂肪分解促進剤。1. The following general formula (1): Lipolysis promoter consisting of. 【請求項2】 下記一般式(1)で示される化合物を含
有することを特徴とする皮膚外用剤。 【化2】
2. A skin external preparation containing a compound represented by the following general formula (1). [Chemical 2]
【請求項3】 皮膚外用剤が皮膚化粧料である請求項2
記載の皮膚外用剤。
3. The external skin preparation is a skin cosmetic.
The skin external preparation described.
【請求項4】 皮膚外用剤が痩身用皮膚化粧料である請
求項2記載の皮膚外用剤。
4. The skin external preparation according to claim 2, which is a skin cosmetic for slimming.
【請求項5】 請求項1記載の脂肪分解促進剤又は請求
項2記載の皮膚外用剤を用いることを特徴とする痩身方
法。
5. A slimming method, which comprises using the lipolysis promoter according to claim 1 or the external skin preparation according to claim 2.
【請求項6】 下記一般式(1)で示される化合物を含
有することを特徴とする痩身用飲食品組成物。 【化3】
6. A slimming food / beverage composition comprising a compound represented by the following general formula (1). [Chemical 3]
JP2001344250A 2001-11-09 2001-11-09 Lipid degradation promoter and method of slimming body Pending JP2003146870A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001344250A JP2003146870A (en) 2001-11-09 2001-11-09 Lipid degradation promoter and method of slimming body

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001344250A JP2003146870A (en) 2001-11-09 2001-11-09 Lipid degradation promoter and method of slimming body

Publications (1)

Publication Number Publication Date
JP2003146870A true JP2003146870A (en) 2003-05-21

Family

ID=19157804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001344250A Pending JP2003146870A (en) 2001-11-09 2001-11-09 Lipid degradation promoter and method of slimming body

Country Status (1)

Country Link
JP (1) JP2003146870A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
JP2019156741A (en) * 2018-03-09 2019-09-19 国立大学法人 筑波大学 Functional composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07215837A (en) * 1994-02-04 1995-08-15 Pola Chem Ind Inc Skin external agent
JPH07223940A (en) * 1994-02-14 1995-08-22 Pola Chem Ind Inc Active oxygen eliminating agent and composition containing the same
JPH08119825A (en) * 1994-10-20 1996-05-14 Ichimaru Pharcos Co Ltd Hydroxytyrosol, application for skin external medicine or bathing agent
WO2002018310A1 (en) * 2000-09-01 2002-03-07 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
WO2003032966A1 (en) * 2001-10-09 2003-04-24 Fancl Corporation Compositions for potentiating glutatthione

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07215837A (en) * 1994-02-04 1995-08-15 Pola Chem Ind Inc Skin external agent
JPH07223940A (en) * 1994-02-14 1995-08-22 Pola Chem Ind Inc Active oxygen eliminating agent and composition containing the same
JPH08119825A (en) * 1994-10-20 1996-05-14 Ichimaru Pharcos Co Ltd Hydroxytyrosol, application for skin external medicine or bathing agent
WO2002018310A1 (en) * 2000-09-01 2002-03-07 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
WO2003032966A1 (en) * 2001-10-09 2003-04-24 Fancl Corporation Compositions for potentiating glutatthione

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
JP2019156741A (en) * 2018-03-09 2019-09-19 国立大学法人 筑波大学 Functional composition
JP7095861B2 (en) 2018-03-09 2022-07-05 国立大学法人 筑波大学 Functional composition

Similar Documents

Publication Publication Date Title
JP4673851B2 (en) Lipolysis promoter and slimming skin external composition
KR100539495B1 (en) Acyl derivatives of glycosy-l-ascorbic acid
JP3968405B2 (en) Antiallergic agent
JP4043220B2 (en) Lipolysis promoter and slimming method
JP2000169325A (en) Promoter for degradation of lipid and skin cosmetic for slimming body
JP2001026538A (en) Food and medicine composition containing new capsaicinoid-like substance
JP2004043373A (en) Lipase inhibitor
EP2397136B1 (en) Anti-inflammatory composition
JP4325908B2 (en) Lipolysis accelerator, skin external preparation and food and drink using the same
JP2004331579A (en) Production promoter of corium matrix
JP2003146870A (en) Lipid degradation promoter and method of slimming body
JP2021504470A (en) Composition for treating atopy or pruritus containing N-acetyl or N-acyl amino acid
JP4630052B2 (en) Lipolysis accelerator, composition for external use on skin and food and beverage composition
JP2007031302A (en) Adiponectin production accelerator and metabolic syndrome preventive
JPH10287582A (en) Suppressant for liberation of histamine comprising bark extract
JP6456032B2 (en) Sirt1 activator and use of the Sirt1 activator
JP4421847B2 (en) Lipolysis accelerator
JP5305418B2 (en) Platelet aggregation inhibitor
JP2001172150A (en) Composition for oral cavity and medicinal composition for external use
JP4542765B2 (en) Enzyme inhibitor
JP7445689B2 (en) lipolysis accelerator
JP6188422B2 (en) Anti-inflammatory agent, hyaluronidase inhibitor, antiallergic agent
JP6740548B2 (en) Hair growth agent containing urolithins, and 5α reductase activity inhibitor containing urolithins
JP6238394B2 (en) Ceramide production promoter
JP2010222356A (en) Lipolysis promoter and cosmetic skin preparation for reducing body weight containing the same

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040805

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040806

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060905

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070130